Investigation of IFI16 modulating molecules on Type I IFN inflammatory mediators following cytosolic DNA sensing or detection of nuclear DNA damage
Project: Research
| Status | Finished |
|---|
| Effective start/end date | 1/10/23 → 31/03/24 |
|---|
- Kymera Therapeutics: £7,585.86
